المؤلفون: Hawkey, Chris¹ (AUTHOR) cj.hawkey@nottingham.ac.uk, Avery, Anthony² (AUTHOR), Coupland, Carol A C² (AUTHOR), Crooks, Colin¹ (AUTHOR), Dumbleton, Jennifer¹ (AUTHOR), Hobbs, F D Richard³ (AUTHOR), Kendrick, Denise² (AUTHOR), Moore, Michael⁴ (AUTHOR), Morris, Clive⁵ (AUTHOR), Rubin, Gregory⁶ (AUTHOR), Smith, Murray⁷ (AUTHOR), Stevenson, Diane¹ (AUTHOR), HEAT Trialists (CORPORATE AUTHOR)

المصدر: Lancet. Nov2022, Vol. 400 Issue 10363, p1597-1606. 10p.

مصطلحات موضوعية: *STATISTICAL sampling, *RESEARCH, PEPTIC ulcer prevention, HELICOBACTER pylori, COMBINATION drug therapy, ANTIBIOTICS, HELICOBACTER, PEPTIC ulcer, ASPIRIN, PRIMARY health care, RANDOMIZED controlled trials, HEAT, HELICOBACTER diseases, COMPARATIVE studies, PREVENTIVE health services, CLARITHROMYCIN, DISEASE complications

المؤلفون: Walker, Jaqui, Hutchison, Pippa, Ge, Junbo, Zhao, Dong, Wang, Yongjun, Rothwell, Peter M, Gaziano, J Michael, Chan, Andrew, Burn, John, Chia, John, Langley, Ruth, O'Donnell, Valerie, Rocca, Bianca, Hawkey, Chris

مصطلحات موضوعية: aspirin, inflammation, primary prevention, secondary prevention, tertiary prevention, colorectal cancer (CRC), cardiovascular disease (CVD), stroke, bleeding, risk, benefit, Lynch syndrome, precision medicine, individualised choice, personalised medicine, hisphilso

العلاقة: http://nrs.harvard.edu/urn-3:HUL.InstRepos:35982184Test

الإتاحة: http://nrs.harvard.edu/urn-3:HUL.InstRepos:35982184Test

المؤلفون: Hawkey, Chris¹ (AUTHOR) cj.hawkey@nottingham.ac.uk

المصدر: Lancet. Apr2023, Vol. 401 Issue 10384, p1266-1266. 1p.

مصطلحات موضوعية: HELICOBACTER pylori, ASPIRIN, PUZZLES

المؤلفون: Rocca, Bianca

المساهمون: Walker, Jaqui, Hutchison, Pippa, Ge, Junbo, Zhao, Dong, Wang, Yongjun, Rothwell, Peter M., Gaziano, J. Michael, Chan, Andrew, Burn, John, Chia, John, Langley, Ruth, O'Donnell, Valerie, Rocca, Bianca, Hawkey, Chris

مصطلحات موضوعية: Lynch syndrome, aspirin, benefit, bleeding, cardiovascular disease (CVD), colorectal cancer (CRC), individualised choice, inflammation, personalised medicine, precision medicine, primary prevention, risk, secondary prevention, stroke, tertiary prevention, Oncology, Cancer Research, Settore BIO/14 - FARMACOLOGIA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/29515654; info:eu-repo/semantics/altIdentifier/wos/WOS:000427092700001; volume:12; issue:Feb 20; firstpage:813; lastpage:820; numberofpages:8; issueyear:2018; journal:ECANCERMEDICALSCIENCE; http://hdl.handle.net/10807/130498Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85044149597; https://ecancer.org/journal/12/pdf/813Test-aspirin-120-years-of-innovation-a-report-from-the-2017-scientific-conference-of-the-international-aspirin-foundation-14-september-2017-charit-berlin.php

الإتاحة: https://doi.org/10.3332/ecancer.2018.813Test
http://hdl.handle.net/10807/130498Test
https://ecancer.org/journal/12/pdf/813Test-aspirin-120-years-of-innovation-a-report-from-the-2017-scientific-conference-of-the-international-aspirin-foundation-14-september-2017-charit-berlin.php